Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.03M$7.03Mderivedno prior Q4 2020 on file Net Income-$3.48M-$3.48MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$6,250,636— Operating Incomederived-$3,412,405— Operating Cash Flowderived-$1,784,358N/M Free Cash Flowderived-$1,926,068N/M Margins · derivedGross margin88.9%
Operating margin-48.5%
Net margin-49.5%
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end